CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,076 enrolled
Drug / intervention
Etonogestrel Implantdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02267616
NCT02267616N/ACompleted
CompareCT.gov

Effectiveness of Prolonged Use of IUD/Implant for Contraception

Indiana University·interventional·Posted Oct 17, 2014·Updated Apr 15, 2021

In Brief

A clinical study evaluating Etonogestrel Implant for Contraception. Completed, enrolled 1,076 participants across 2 sites.

Detailed Summary

This study will evaluate LNG-IUD and Etonogestrel (ENG) Implant users who are willing to use their contraception beyond the end of the FDA-approved duration. ENG Implant users will also be offered to participate in an arm of the study that will randomize them to either keeping their implant in or having it removed and replaced with a new implant. Participants will be followed for up to three years.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsContraception
CountriesUnited States
CollaboratorsSusan Thompson Buffett Foundation

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedOct 17, 2014
Enrollment StartDec 1, 2011
Primary CompletionMar 31, 2021
TodayJul 2, 2026
Enrollment to primary: 9.3 yearsPosted 11.7 years ago

Interventions

Etonogestrel Implantdevice

Subdermal arm implant